Stockholders' Equity - Narrative (Details)					12 Months Ended			179 Months Ended
	Aug. 27, 2024 USD ($)	May 07, 2024 $ / shares shares	Mar. 27, 2024 USD ($) $ / shares shares	Feb. 13, 2023 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) period $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2024 USD ($) period $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award
Common stock, shares authorized (in shares) | shares					400,000,000	400,000,000		400,000,000
Common stock, par value (in dollars per share) | $ / shares					$ 0.01	$ 0.01		$ 0.01
Preferred stock, authorized (in shares) | shares					100,000,000			100,000,000
Preferred stock, par value (in dollars per share) | $ / shares					$ 0.01			$ 0.01
Number of shares issued (in shares) | shares					5,329,544
Weighted average offering price (in dollars per share) | $ / shares					$ 66.62	$ 61.15	$ 61.31
Issuance of common stock (in shares) | shares						5,152,279	1,286,125
Underwriting discount and offering costs					$ 6,314,000	$ 5,830,000	$ 1,557,000
Shares repurchase program, authorized repurchase amount (in shares) | shares					3,000,000			3,000,000
Withdraw from deferred compensation plan (in shares) | shares					11,473	5,876	8,929
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Granted (in shares) | shares					138,380	132,574	136,903
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares					$ 63.48	$ 61.58	$ 66.35
Expense					$ 6,800,000	$ 6,300,000	$ 4,900,000
Fair value of the restricted stock granted					8,800,000
Unrecognized compensation costs related to restricted stock issuances					$ 14,400,000			$ 14,400,000
Remaining weighted average period (years)					3 years 2 months 12 days
Minimum | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares								$ 14.20
Vesting period for the restricted stock (years)					3 years
Maximum | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares								$ 78.33
Vesting period for the restricted stock (years)					5 years
Common Shares Held in Deferred Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award
Deposits to deferred compensation plan (in shares) | shares					0	96,874	150,867
2019 Plan
Share-based Compensation Arrangement by Share-based Payment Award
Common stock, shares authorized (in shares) | shares					1,898,961			1,898,961
Granted (in shares) | shares		11,385
Grant date fair value per share of restricted stock awards (in dollars per share) | $ / shares		$ 54.90
Expense					$ 600,000
Remaining balance of shares available (in shares) | shares					367,561			367,561
Long Term Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares issued (in shares) | shares					0
Number of measurement periods | period					3			3
$500 Million ATM Program
Share-based Compensation Arrangement by Share-based Payment Award
Common stock aggregate offering price					$ 500,000,000.0
Common stock remaining offering price					438,300,000			$ 438,300,000
Net proceeds form offerings					349,900,000	$ 310,500,000
Total compensation to the applicable sales agents					$ 5,100,000	4,600,000
Previous At Market Equity Offering Program 500 Million
Share-based Compensation Arrangement by Share-based Payment Award
Common stock aggregate offering price	$ 500,000,000
$300 Million ATM Program
Share-based Compensation Arrangement by Share-based Payment Award
Common stock aggregate offering price	$ 300,000,000						$ 300,000,000
Net proceeds form offerings							77,700,000
Total compensation to the applicable sales agents							$ 1,100,000
Previous At Market Equity Offering Program 300 Million
Share-based Compensation Arrangement by Share-based Payment Award
Net proceeds form offerings						310,500,000
Total compensation to the applicable sales agents						$ 4,600,000
IPO | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares issued (in shares) | shares			6,325,000	5,750,000
Net proceeds form offerings			$ 387,100,000	$ 355,900,000
Shares issued, price per share (in dollars per share) | $ / shares			$ 62.00	$ 62.50
Underwriting discount and offering costs			$ 5,000,000	$ 3,500,000
Over-Allotment Option | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares issued (in shares) | shares			825,000	750,000